Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance

Uncovering the pathogenesis of large granular lymphocytic leukemia—novelSTAT3andSTAT5bmutations

(2014) Hanna L. M. Rajala et al.   ANNALS OF MEDICINE

STAT3 Inhibitors: Finding a Home in Lymphoma and Leukemia

(2014) J. Munoz et al.   ONCOLOGIST

Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse

(2014) Takayuki Yoshimoto et al.   OncoImmunology

Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance

(2014) Eva Putz et al.   Cancers

ATM-dependent spontaneous regression of early E -myc-induced murine B-cell leukemia depends on natural killer and T cells

(2013) J. L. Croxford et al.   BLOOD

STAT inhibitors for cancer therapy

(2013) Muhammad Furqan et al.   Journal of Hematology & Oncology

Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma-Induced Immune Suppression

(2013) X. Sun et al.   MOLECULAR CANCER THERAPEUTICS

EGFR-Targeted Granzyme B Expressed in NK Cells Enhances Natural Cytotoxicity and Mediates Specific Killing of Tumor Cells

(2013) Pranav Oberoi et al.   PLoS One

Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma

(2013) Sina Haftchenary et al.   ACS Medicinal Chemistry Letters

Identification of Resting and Type I IFN-Activated Human NK Cell miRNomes Reveals MicroRNA-378 and MicroRNA-30e as Negative Regulators of NK Cell Cytotoxicity

(2012) P. Wang et al.   JOURNAL OF IMMUNOLOGY

SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia

(2012) Hanna L.M. Koskela et al.   NEW ENGLAND JOURNAL OF MEDICINE

Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance

(2012) Tatsuaki Mizutani et al.   OncoImmunology

Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity

(2011) T.-D. Kim et al.   BLOOD

Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells

(2011) R. Bedel et al.   CANCER RESEARCH

Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients

(2011) Beatriz Sanchez-Correa et al.   IMMUNOLOGY AND CELL BIOLOGY

A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development

(2010) E. Eckelhart et al.   BLOOD

Next-generation sequencing identifies the natural killer cell microRNA transcriptome

(2010) T. A. Fehniger et al.   GENOME RESEARCH

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

(2009) Tadepally Lakshmikanth et al.   JOURNAL OF CLINICAL INVESTIGATION

DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases

(2009) C. J. Chan et al.   JOURNAL OF IMMUNOLOGY

RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22–producing NKp46+ cells

(2008) Stephanie L Sanos et al.   NATURE IMMUNOLOGY